Q-linea as an investment
Welcome to the Investor Relations section. Here we have gathered important information about Q-linea for existing investors and others who are interested in our business.
NASDAQ Stockholm(QLINEA): Quotes are delayed 15 minutes
0.039
SEK-4.65
percentQ-linea as an investment
Welcome to the Investor Relations section. Here we have gathered important information about Q-linea for existing investors and others who are interested in our business.
NASDAQ Stockholm(QLINEA): Quotes are delayed 15 minutes
0.039
SEK-4.65
percentFuture-proof Healthcare
CEO Jonas Jarvius explains how Q-linea is intimately tied to his experiences of healthcare inequity, and how Q-linea is working to ensure we have sustainable and equitable healthcare, now and in the future.
Press releases
Q-linea announces strong support of the TO1 warrant program as well as an extension of existing loan from large shareholder
Interim report 1 January – 31 March 2025
First ASTar® evaluation in Abu Dhabi, United Arab Emirates
Q-linea AB (publ) (OMX: QLINEA) today announces the initiation of the first clinical evaluation of ASTar at Sheikh Kalifa…
Read more >
Keep up to date – subscribe
Christer Samuelsson
Investor Relations
Phone: +46 18 444 36 10
Mobile: +46 70 600 15 20
.
.
.